Insights On Outsourced Drug Development

  1. Beyond SOPs: Assessing Quality Of CDMOs 5/16/2024

    When choosing a CDMO partner, it is essential to prioritize quality. Discover how the right partner can instill confidence in the safety and effectiveness of your pharmaceutical products.

  2. Efficient Stem Cell Expansion In Bioreactors For Immunotherapy 12/9/2025

    A scalable bioreactor process enables efficient expansion of cord blood-derived HSCs and NK cell differentiation, delivering high purity and strong cytotoxicity, advancing immune cell therapies.

  3. Accelerating Clinical Development: Modern Tools In Process Chemistry 1/23/2025

    Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

  4. Functional Characterization Of 3D Assembled Neurospheres 4/4/2025

    Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.

  5. Streamlining Cell Line Development For Antibodies 8/27/2025

    Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.

  6. How To Reduce Batch Loss In Biopharma Production 12/12/2025

    Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.

  7. Characterization Of Pharmaceutical Materials With Modulated DSC 12/30/2024

    Modulated DSC addresses challenges in pharmaceutical material characterization, enabling precise analysis of glass transitions, and overlapping transitions, enhancing insights beyond standard DSC.

  8. AustinPX Site Tour 5/2/2025

    Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.

  9. Facts About AAV Producer Cell Lines 8/8/2025

    Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

  10. Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease 10/8/2024

    Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.